ADK

Across TCGA pan-cancer cohorts, ADK Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ADK data layer compared with 23 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ADK Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ADK expression acts as an unfavorable survival marker.

BLCA, KIRP, and UCEC are the cancer types where ADK Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	IV	0.130	0.599	.002	12	view →
KIRP	OS	Median	II,III,IV	0.188	0.771	.016	10	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ADK–BLCA (OS)

Open the BLCA breakdown →